Noom’s Post

Are patient information leaflets (PILs) clear for everyone to understand? It's crucial for patient safety that patient information leaflets are easy to read. Providing clear instructions can significantly enhance patient compliance with their treatment plans while also fulfilling important regulatory requirements. At PLG, our team specializes in tailoring PILs to meet these standards and ensure patients can easily understand and adhere to the provided instructions. To learn more about how readability testing can ensure the safe and effective use of medicines, we invite you to read our most recent article available here: https://lnkd.in/dYmWr2kz Through our readability testing methods and experts, we aim to meet industry standards and ensure that every patient has the knowledge they need to make informed health decisions. Discover more about our services and expertise in Readability Testing: https://lnkd.in/dQ_C_5-2.

GLP-1s are the hottest conversation in #healthcare right now. For some, it's a game-changer. For others, it's a life-long medication that comes with a lot of what-ifs. In either case, it's a situation that our healthcare system isn't equipped to handle. Ultimately, you want your employees to feel their best so they can be their best. So let's talk about how to do that! Join Noom on April 3 for a discussion on how Noom’s GLP-1 Companion can help close the care gap for your GLP-1 population. #employeebenefits #healthcarebenefits #weightmanagement

🗣️ Let’s talk GLP-1s. While these medications are game-changers for weight loss, they can leave people in worse health than before without the necessary lifestyle change. Yet our #healthcare system isn’t well-equipped to offer support: Primary care clinicians are overwhelmed with GLP-1 demand - and don’t have the time or resources to keep up - fueling the care gap, leaving patients vulnerable to health risks, and exacerbating costs for payers. 💸 Join industry experts Linda Anegawa, MD, Dipl. ABOM, DNBPAS and Alexander Fabry for Noom’s latest live webinar: Bridging the GLP-1 Care Gap for Better Outcomes and ROI. Save your seat here: https://lnkd.in/eS8tPMiy

RHC would like to underscore that it is important for the federal government and its provincial and territorial partners to create formal and ongoing opportunities for patient groups to offer their input and advice.   The ultimate success of any public policy – including the national Pharmacare Act – depends on a critical combination of goal clarity and implementation excellence, and patient groups have a key role to play in achieving both.   Read our full position paper on the national Pharmacare Act here: https://lnkd.in/e26xCC9B   #FederalBudget2024

What's better than hype? Results. Experience the power of GLP-1 medication through a controlled, concierge experience. Your terms, your schedule, with the knowledge of a trained clinical team at your fingertips. Reduce symptoms and maximize sustained results. Book your consultation today! https://lnkd.in/g2ft_A-9

🗣️ Let’s talk GLP-1s. While these medications are game-changers for weight loss, they can leave people in worse health than before without the necessary lifestyle change. Yet our #healthcare system isn’t well-equipped to offer support: Primary care clinicians are overwhelmed with GLP-1 demand - and don’t have the time or resources to keep up - fueling the care gap, leaving patients vulnerable to health risks, and exacerbating costs for payers. 💸 Join industry experts Linda Anegawa, MD, Dipl. ABOM, DNBPAS and Alexander Fabry for Noom’s latest live webinar: Bridging the GLP-1 Care Gap for Better Outcomes and ROI. Save your seat here: https://lnkd.in/eS8tPMiy #noom #glp1 #ozempic #wegovy

By implementing these strategies, you can can enhance your competitiveness in the market while contributing to increased access to affordable medications for patients. https://lnkd.in/dAdEmn2b

The True Value of Premium Products: Beyond the Price Tag. (Part 4) Premium products often exceed industry standards, offering enhanced safety features and compliance with rigorous regulatory requirements. In the medical sector, this is non-negotiable, as it directly impacts patient care and outcomes.

Today, we honor the commitment to protecting patients in every healthcare setting, especially those participating in clinical research. Their safety is our top priority, ensuring ethical standards and the highest levels of care throughout every study. Together, we work towards safer, more reliable healthcare innovations. #PatientSafety #ClinicalResearch #WorldPatientSafetyDay #HealthcareInnovation #CRO

Did you know that scheduled Medicare cuts may jeopardize access to many laboratory tests patients rely on? We stand with the American Clinical Laboratory Association (ACLA) and other organizations in the Saving Access to Laboratory Services Act (SALSA) Day of Action. Join the conversation this #LabWeek and urge Congress to #StopLabCuts and pass the Saving Access to Laboratory Services Act (#SALSA). Make your voice count: https://lnkd.in/gK_ryjuw.